ArticleMelanoma research2024

Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma.

Sarah E Lochrin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.